Patent: 10,822,376
✉ Email this page to a colleague
Summary for Patent: 10,822,376
| Title: | Biologically active peptides |
| Abstract: | A peptide or peptide derivative comprising: (i) WDLYFEIVW (SEQ ID NO:1); or (ii) a variant amino acid sequence comprising one, two, three or four L-amino acid substitutions in WDLYFEIVW (SEQ ID NO: 1); or (iii) the retro-inverso variant of the peptide or peptide derivative of either one of parts (i) and (ii), wherein said peptide or peptide derivative has procoagulant activity. A peptide or peptide derivative comprising: (i) an amino acid sequence comprising imfwydcye; or (ii) a variant amino acid sequence comprising one, two, three, four, five or six amino acid substitutions in imfwydcye, wherein said peptide or peptide derivative has procoagulant activity. |
| Inventor(s): | Scheiflinger; Friedrich (Vienna, AT), Dockal; Michael (Vienna, AT) |
| Assignee: | Baxalta GmbH (Opfikon, CH) Baxalta Incorporated (Bannockburn, IL) |
| Application Number: | 16/359,763 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,822,376
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.s.a., Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | December 21, 1979 | 10,822,376 | 2039-03-20 |
| Takeda Pharmaceuticals U.s.a., Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | July 31, 2000 | 10,822,376 | 2039-03-20 |
| Takeda Pharmaceuticals U.s.a., Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | August 11, 2005 | 10,822,376 | 2039-03-20 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
